chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She developed vomiting multiple times on the morning of 11/29 (almost 48 hours after vaccination). She had no symptoms prior to the vomiting. That evening she complained of pain in her side. The pain was mild, but persisted. On the evening of 12/2, she developed a fever so we went to the ER where she was diagnosed with appendicitis. Surgery on 12/3 revealed a perforated appendix.
Chest pain; Shortness of breath; Feelings of having a fast-beating, fluttering, or pounding heart; Injection on the mussle; Difficulty breathing; Swelling of your face and throat; A fast heartbeat; A bad rash all over your body Dizziness and weakness; Stroke indicatores
A report has been received from a Health Professional concerning a 25 years old female patient. The patient's medical history and concomitant medications were not reported. On 02-Oct-2012, the patient FLUMIST (Intranasal). The patient was pregnant at the time she received vaccine. Upon follow-up patient stated she had her baby girl delivered with weight: 6 pounds and 8 ounces, length: 20 inches and she was a healthy baby with no medication use or health issues. At the time of reporting the outcome of the event was unknown. The report was considered to be non-serious by company physician. Corrected report: Drug start and stop date, Event start date as 02-Oct-2012 added. Age at onset calculated. Summary of follow-up information received by AstraZeneca/MedImmune from registered nurse on 23-Oct-2012: Patient contact details added. Corrected report 19-Nov-2012: The event of administration to newly pregnant female has become a KUR term: therefore the case has been updated accordingly. Summary of follow-up information received by AstraZeneca/MedImmune 26-Jul-2013 from consumer: pregnancy and date, result added.
got the shot and still got shingles / Suspected Vaccination Failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional case details were reported as follows: The reporter was patients family member. The age at vaccination was not reported. The patient got the shot and still got shingles. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.
rash,shakiness,difficulty in breathing;c/o rash-macular papular,itchy x 5 hrs,chest tightness,swelling of nasal cavity,throat & ears;vomiting x 1;MMR given 1600-rxn 0400;heart irreg rhythm;lungs-CTA bilat;some epigast tenderness /w palpitat
1-2 days later patient reports bilateral upper extremity pain.  Radiates from her shoulder all the way down to her waist.  Feels similar to herpes simplex infection previously. No visible rash. Gabapentin prescribed for a "post-herpetic" type neuralgia. Pain remains constant +1 week since vaccination.
About 1 week after my vaccine I started getting red bumps on my knuckles, it was itchy, red and raised. It proceeded to cover my entire hand. It took a couple weeks to clear up. The Dr. put me on a topical and oral steriod.  Still have small bumps pop up from time to time, do not cause any discomfort
Bad fever/ fever 102, 103; body ache for 24 hours/ my body was hurting me; Shivering like for hours like less, less than 24 hours; This is a spontaneous report from a contactable consumer (patient) via Pfizer sponsored program COVAX Support. A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot number: FC3180, Expiration date: Unknown) via an unspecified route of administration on 09Aug2021 as Dose 1, Single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The report was related to a study or programme. On 10Aug2021, she experience bad fever and body ache for 24 hours. Her concern was she had fever like a couple hour after she had a Pfizer vaccine. She had fever 102, 103, she was shivering like for hours like less, less than 24 hours, she said for less than 10 hours she had a fever. She had fever, she was shivering, her body was hurting her/body ache for 24 hours and then like up to like 24 hours she get better." Now she was scheduled for the second dose today which was the exactly the 21st day. She was asking if, it was okay to take it after she had experienced a bad fever, body ache for 24 hours. She stated that lot number as "FC3180 (Not clarified). This was the number of vaccine: FC3180." Expiry Date of Covid 19 vaccine: Unknown. She was informed about the Pfizer Medical Information. Limited information available over the call. The patient underwent lab tests and procedures which included body temperature: 102, 103 (units unspecified) on 09Aug2021 102, 103. The outcome of the events was recovering.  No follow-up attempts are possible. No further information was expected.
I did not have an adverse reaction to the vaccine. I tested positive COVID-19 on 5/25/2022. I took a home test and I had a PCR test at the hospital I work at. I had a sore throat, headache and fatigue. I took TYLENOL to help with my symptoms. I had a telehealth visit with my provider and was prescribed PAXLOVID for my symptoms.
Family came in 6/2/11 for additional vaccines. This family is very anxious about vaccination and is having us give one or two shots at a time. As we were discussing which shots to give they reported fever "very high" 101.8 forehead strip and continuous crying after the April 1, 2011 shots. They said she was very hard to console. This lasted a long time hard to tell if it was 3 hours of inconsolable crying.
Headache, Myalgia, NauseaVomiting, chills, joint pain, fatigue Narrative:
Patient started having significant chest pain with radiating pain down right arm 3 days after vaccination. ED labs pulled showed possible NSTEMI. Admitted with workup. Cath showed no CAD. Developed headache on day 5. CT performed. Sent home on oxycodone and ibuprofen. Seen in my office today with some continued chest pain but headache unchanged.
turned pale & limp & became unresponsive in mom arms on 24SEP93; taken to ER cont to be pale & limp for total of 15-20mins somewhat limp & lethargic in ER; transported to hosp;
Severe paint in joints-arms, hands, feet and both knees on Saturday.  By Sunday morning hands and arms were 90% better but knees were bad and I had to use a walker to get up from a sitting position and to walk.  Monday left knee 90% better but right knee (knee replacement) bad.  Tuesday morning very light pain in left knee and right knee is about 90%better, no pain in arms or hands.
no adverse effects; a patient was administered an expired dose of PNEUMOVAX 23; Information has been received from a medical assistant referring to a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported.  On 10-APR-2019, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot# N024717, expiration date was 06-APR-2019,dose was not provided), intramuscularly, for prophylaxis. No adverse effects were reported.
extreme weakness; Felt very sick; Diarrhea; Muscle weakness; Decreased appetite; rash on her arm at the injection site; Swelling at the injection site probably about the size of my fist; Very, very itchy, swelling at injection site; Thinks its some sort of allergic reaction; Injection site red; Pain; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Thinks its some sort of allergic reaction), PAIN IN EXTREMITY (Arm, of course, was extremely sore and lasted about a week), VACCINATION SITE ERYTHEMA (Injection site red), ASTHENIA (extreme weakness) and ILLNESS (Felt very sick) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced HYPERSENSITIVITY (Thinks its some sort of allergic reaction), VACCINATION SITE ERYTHEMA (Injection site red), VACCINATION SITE SWELLING (Swelling at the injection site probably about the size of my fist) and VACCINATION SITE PRURITUS (Very, very itchy, swelling at injection site). 26-Jan-2021, the patient experienced VACCINATION SITE RASH (rash on her arm at the injection site). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm, of course, was extremely sore and lasted about a week), ASTHENIA (extreme weakness), ILLNESS (Felt very sick), DIARRHOEA (Diarrhea), MUSCULAR WEAKNESS (Muscle weakness) and DECREASED APPETITE (Decreased appetite). At the time of the report, HYPERSENSITIVITY (Thinks its some sort of allergic reaction), PAIN IN EXTREMITY (Arm, of course, was extremely sore and lasted about a week), VACCINATION SITE ERYTHEMA (Injection site red), ASTHENIA (extreme weakness), ILLNESS (Felt very sick), DIARRHOEA (Diarrhea), MUSCULAR WEAKNESS (Muscle weakness), DECREASED APPETITE (Decreased appetite), VACCINATION SITE RASH (rash on her arm at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site probably about the size of my fist) and VACCINATION SITE PRURITUS (Very, very itchy, swelling at injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant products were reported. No Treatment were reported. Patient had Trouble staying awake, severe generalized pain. The second planned dose was scheduled on 16FEB2021. Unknown if the patient received.   Most recent FOLLOW-UP information incorporated above includes: On 12-Feb-2021: Patient demographics was updated. Treatment with mRNA-1273 was updated. Additional events of hypersensitivity, pain in extremity and injection site pruritus were reported. The patient's doctor told her to monitor it and come in if it got worse. On 24-Jun-2021: Events outcome was updated. The reporter declined further follow-up.
Normal labor and delivery on (Privacy). Hospital admission was within 6 weeks of receiving the COVID vaccine.
a patient who might benefit from the Paxlovid; a patient who might benefit from the Paxlovid; This is a spontaneous report received from a contactable reporter(s) (Physician), Program ID.  A female patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "a patient who might benefit from the Paxlovid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of drug ineffective, suspected covid-19. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received. Additional information: The patient got the booster dose a week ago.
pt recvd fluogen vax but was supossed to received the 1993 vax instead to 1992 vax; This case is one of 3 pts who recvd inadvertent administartion of the 1992 vax;
11/14 - MMR vaccine at 1 year appointment 11/15 - tender 11/22 - Fever...tylenol 11/23 - Rash...tylenol and benedryl
Post vax, the RN reported that on 12/08/2000 the patient developed chicken pox. Additional information has been requested.
Fully vaccinated patient who admitted through ED with COVID.  Provider d/c note:  "Patient is a 90 YO female with h/o hypertension, dm 2, HFrEF with pacemaker, morbid obesity admitted for failure to thrive secondary to COVID-19 pneumonia along with hypoxia and acute kidney injury.  Patient was treated with full course of Decadron and remdesivir with resolution of hypoxia. CT PE had shown pulmonary embolism involving the segmental pulmonary artery branch of the left lower lung for which patient was started on Eliquis twice a day and would recommend patient be maintained on this for 3 months has suspect this was likely provoked in setting of COVID infection.  Acute kidney injury had resolved by time of discharge.  Patient with failure to thrive and decreased mobility and will be discharged to skilled nursing facility to increase strength."
Pain at tetanus injection site started 24 hrs after shot given.  Pain using L arm, aching in L arm and R arm.
Fever; Chills; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number was not reported, NDC number, UPC number, expiry date were reported as unknown) via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced fever and chills on an unspecified date. The events were reported as non-serious. The patient asked if there was a need to visit the hospital, or this were common side effect which will eventually subside. The outcome of both the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Initial soreness followed by increased soreness, 11/17/99. Swelling in deltoid region, slight redness. 11/22/99 states that soreness is improving.
Fatigue, Migraine, Chills  Hives on face 1 hour after 3rd dose Asthma inflammation - mucous, extreme chest tightness 24-36 hours after 3rd dose; asthma flare-up lasted 2 weeks, Neck lymph nodes swollen, Menstruation (cycle) changed, Inflammation chest cartilage, Constant back aches, Sinus infection with benign positional vertigo
a hard raised lump developed that has grown a bit; itchy; red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (a hard raised lump developed that has grown a bit), INJECTION SITE PRURITUS (itchy) and INJECTION SITE ERYTHEMA (red) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced VACCINATION SITE INDURATION (a hard raised lump developed that has grown a bit), INJECTION SITE PRURITUS (itchy) and INJECTION SITE ERYTHEMA (red). At the time of the report, VACCINATION SITE INDURATION (a hard raised lump developed that has grown a bit), INJECTION SITE PRURITUS (itchy) and INJECTION SITE ERYTHEMA (red) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No information regarding corrective treatment was reported by the patient.
In September, October and November, 1999, the pt received Lymerix vaccines. Immediately, after each injection (exact date not provided), he had pain which resolved. Then in January, 2000, he experienced a severe flare-up of pain in his knees and his thighs. The most recent information received on 2/17/2000, indicates the outcome of the symptoms as unknown. Additional information has been requested.
The patient had a syncopal episode 15 minutes after immunization when she stood.  She continued to be nauseated and have vomiting for approximately 75 minutes after her syncope.  She talked very little and did not want to answer questions.  Her vital signs- HR, BP, RR were normal.  She was more interactive when she left the office.
Had seizure at restaurant that lasted 30 seconds; no prior hx of seizures; no family hx of seizures.
This case was reported by a physician via sales rep and described the occurrence of delirium in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced delirium (serious criteria GSK medically significant). On an unknown date, the outcome of the delirium was unknown. It was unknown if the reporter considered the delirium to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The reporter gave consent for follow up. This case is linked to case US2019AMR069893, reported by the same reporter.
Patient got Tetanus shot on 6-3-10 was given subcutaneously not intramuscular as recommended. Site redness, warm to touch and pain, escorted pt to ER since she was very concern due to nursing her infant. Recommended: Warm compress/MOTRIN for pain/watch area for increased redness.
Bottom lip, chin, jawline feels numb; Bitter taste; hives on forearm, left and right wrist to elbow; A spontaneous report was received from a registered respiratory therapist concerning a 38 year-old, female patient participating in the mRNA-1273 Emergency Use Program and experienced hives on forearm (right and left wrist to elbow), bottom lip numbness, chin numbness, jawline numbness, and bitter taste.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On 24 Dec 2020, approximately 24 hours prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (025J20A) intramuscularly for prophylaxis of COVID-19 infection.   On 25 Dec 2020, the patient started to experience hives on her left and right forearm, from wrist to elbow. Self-treatment with Benadryl for this event caused symptoms to reside for 45 mins. On 26 Dec 2020, the patient experienced numbness of her bottom lip, chin, and jawline spreading to the neck up to the left side of the face. Patient notes this feeling as "like getting a Novocain injection". On 26 Dec 2020, the patient also began to experience bitter taste. Treatment for the event included diphenhydramine hydrochloride.   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events hives on forearm (right and left wrist to elbow), bottom lip numbness, chin numbness, jawline numbness, and bitter taste were not reported.; Reporter's Comments: This case concerns a 38-year-old female patient who received their first of two planned doses of mRNA-1273 (Lot 025J20A), and who experienced the non-serious unlisted events of Urticaria, Hypoaesthesia, and Dysgeusia.  Based on the current available information and temporal association between the use of the product and the onset of events starting on the day after vaccination, a causal relationship cannot be excluded and the events are considered possibly related to the vaccine.
2 days after DTaP/ HIB, developed fine bumps with knot at site; then spread to upper extremities and trunk: had cough/ rhinorhea 4 days later.
I had the shot, I had shingles/ suspected vaccination failure; shingles; mouth blisters; couldn't eat or drank; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 6 months after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, blistering of mouth and feeding disorder. On an unknown date, the outcome of the vaccination failure, shingles, blistering of mouth and feeding disorder were unknown.   It was unknown if the reporter considered the vaccination failure, shingles, blistering of mouth and feeding disorder to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The reporter stated that, had the shot and got mouth broke out in blisters, could not eat or drank, and 6 months later had shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.
In 2nd week after 2nd shot became very dehydrated headache, general not feeling well, but could funtion.
tachycardia that lasted 20-30mins then resolved;fine now;only very minor local sx w/some minor h/a & nausea which did not need any treatment;has a hive a wrist on inj site arm;states lots of stress as a result of personal events
they got blood work that showed that their thyroid issue; This spontaneous case was reported by a patient and describes the occurrence of THYROID DISORDER (they got blood work that showed that their thyroid issue) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013H2RB, 026D21A and 011D21A) for COVID-19 prophylaxis.     Concurrent medical conditions included Rheumatoid arthritis and Hypertension.   On 02-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2022, the patient experienced THYROID DISORDER (they got blood work that showed that their thyroid issue). The patient was treated with METHIMAZOLE for Thyroid disorder NOS, at a dose of 10 milligram. At the time of the report, THYROID DISORDER (they got blood work that showed that their thyroid issue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2022, Blood test: showed thyroid issue..         Patient was on medication for Rheumatoid Arthritis and High blood pressure.
Increased BP, flushing, metallic taste in mouth, fever up to 101.0
RED and SWOLLEN AT INJECTION SITE. MILD RASH AT INJECTION SITE.
Information has been received from an office worker concerning a female nurse who developed diarrhea and vomiting after administering rotavirus to a patient. The nurse was subsequently hospitalized (duration unknown). It was not know if the nurse had any direct contact with the vaccine or if the patient she was vaccinating spit out the vaccine after it was administered. At the time of this report, the nurse's diarrhea and vomiting persisted. Additional information has been requested.
Severe headache, nausea, diarrhea, green bowel and vomit for about 36 hours.
Dnr woke up at 630 am on 2-12-12 c/o fever, nausea, fatigue & diarrhea and was sweating. Degree of temp unknown - Donor did not take temp. This lasted for three days.
5 days p/3rd dose of Engerix-B pt exp flu-like sx, h/a, stiff neck, malaise, nausea that persisted 5 days;